Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MC Regular
- Development stage
- Unknown
- Lead developer
- DEMECAN
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Inhalation
01
Overview
MC Regular (also known as MC Regular Drop) is a medical cannabis flower product distributed by DEMECAN in Germany. Sourced from Canadian cultivation (such as Mill Creek Growth), this un-irradiated (unbestrahlt) cannabis flower is available in several cultivars, including 'Glitter Pop Bomb' (Glitter Bomb x Gastro Pop #5), 'Sherbet Mints' (Sunset Sherbet x Kush Mints #11), 'GMO x Jet Fuel Gelato', and 'Secret Weapon X Cookies n Cream' (Oreoz). It typically contains approximately 24% to 27% tetrahydrocannabinol (THC) and less than 1% cannabidiol (CBD). MC Regular is prescribed for the treatment of various conditions, including chronic pain, depression, anxiety, sleep disorders (insomnia), ADHD, and post-traumatic stress disorder (PTSD). The active cannabinoids, primarily THC, act as partial agonists on cannabinoid receptors CB1 and CB2 to modulate pain, mood, and sleep.
- Brand names
- MC Regular Drop
- Other names
- Demecan MC Regular DropMC Regular Drop 24:01MC Regular Drop 25/1MC Regular Drop 25:01MC Regular Drop 27/1
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on MC Regular.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MC Regular.